Podcast Episodes
Back to Search
ProPhase Labs announces LOI for reverse merger with Advanced Biological
Episode 13759
ProPhase Labs CEO Ted Karkus joined Steve Darling from Proactive to announce that the company has entered into a non-binding Letter of Intent (LOI) r…
2 months, 2 weeks ago
Cabbacis prepares for U.S. launch of low-nicotine iBlend products
Episode 13760
Cabbacis CEO Joe Pandolfino joined Steve Darling from to discuss the company’s strategic preparations to enter the U.S. market with its proprietary l…
2 months, 2 weeks ago
Happy Creek reports strong Tungsten assays from 2025 drilling at Fox project
Episode 13758
Happy Creek Minerals CEO Steve Gray joined Steve Darling from Proactive to share details of the company’s latest assay results from its 2025 diamond …
2 months, 2 weeks ago
Ilika begins shipping Stereax M300 prototypes, reaching key commercial milestone
Episode 13756
Ilika CEO Graeme Purdy joined Steve Darling from Proactive to announce that the company has begun shipping prototype Stereax M300 solid-state batteri…
2 months, 2 weeks ago
Skyler Weinand on rate cuts and bond strategies
Episode 13755
Regan Capital CIO Skyler Weinand joined Steve Darling from Proactive to share news about the dynamics of the fixed income markets, interest rates, an…
2 months, 2 weeks ago
Standard Uranium maps 2026 growth after strong funding and JV progress in 2025
Episode 13754
Standard Uranium CEO Jon Bey joined Steve Darling from Proactive to discuss the company’s operational progress throughout 2025 and outline its strate…
2 months, 2 weeks ago
1911 Gold launches 2,200 metre drill program at Ogama-Rockland gold deposit
Episode 13753
1911 Gold Corporation Chairman Gary O’Connor joined Steve Darling from Proactive to announce the start of a 2,200-metre diamond drilling program at t…
2 months, 2 weeks ago
BioVie advances Parkinson’s, long COVID, and liver disease programs ahead of 2026
Episode 13752
BioVie CEO Cuong Do joined Steve Darling from Proactive to provide an update on the company’s recent progress across its two lead drug candidates, Be…
2 months, 2 weeks ago
2025.12.17 Tiziana Life Tiziana Life Sciences doses first patient in Phase 2 Alzheimer’s clinical trial Ltd
Episode 13751
Tiziana Life Sciences CEO Ivor Elrifi joined Steve Darling from Proactive to announce a key clinical milestone, confirming that the first patient has…
2 months, 2 weeks ago
Allergy Therapeutics CEO on grass vaccine milestone and next steps
Episode 13750
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) chief executive Manuel Llobet talked with Proactive's Stephen Gunnion about the granting of approval fo…
2 months, 2 weeks ago